Trial Profile
A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy - The SUMMIT Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Acronyms SUMMIT
- Sponsors ALK-Abello
- 20 Jan 2014 Status changed from active, no longer recruiting to completed as reported by the ClinicalTrials.gov record.
- 15 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Dec 2012 New trial record